SK14298A3 - Use of griseofulvin for inhibiting the growth of cancers - Google Patents

Use of griseofulvin for inhibiting the growth of cancers Download PDF

Info

Publication number
SK14298A3
SK14298A3 SK142-98A SK14298A SK14298A3 SK 14298 A3 SK14298 A3 SK 14298A3 SK 14298 A SK14298 A SK 14298A SK 14298 A3 SK14298 A3 SK 14298A3
Authority
SK
Slovakia
Prior art keywords
agents
griseofulvin
pharmaceutical composition
tumors
chemotherapeutic agent
Prior art date
Application number
SK142-98A
Other languages
English (en)
Slovak (sk)
Inventor
James B Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK14298A3 publication Critical patent/SK14298A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK142-98A 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers SK14298A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
SK14298A3 true SK14298A3 (en) 1998-09-09

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
SK142-98A SK14298A3 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Country Status (16)

Country Link
EP (1) EP0841914A2 (ja)
JP (1) JPH11511136A (ja)
KR (1) KR19990036137A (ja)
AR (1) AR003176A1 (ja)
AU (1) AU713031B2 (ja)
BR (1) BR9609920A (ja)
CA (1) CA2228503A1 (ja)
CZ (1) CZ30598A3 (ja)
HU (1) HUP9903506A3 (ja)
IL (1) IL123094A0 (ja)
MX (1) MX9800945A (ja)
NO (1) NO980420L (ja)
PL (1) PL324905A1 (ja)
SK (1) SK14298A3 (ja)
TR (1) TR199800244T2 (ja)
WO (1) WO1997005870A2 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1098641B1 (en) * 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
KR20010103655A (ko) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
CN101816794A (zh) * 2001-06-25 2010-09-01 味之素株式会社 抗肿瘤剂
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
HUP9903506A2 (hu) 2000-06-28
PL324905A1 (en) 1998-06-22
HUP9903506A3 (en) 2000-07-28
EP0841914A2 (en) 1998-05-20
CA2228503A1 (en) 1997-02-20
CZ30598A3 (cs) 1998-06-17
KR19990036137A (ko) 1999-05-25
AU6683496A (en) 1997-03-05
TR199800244T2 (xx) 1998-09-21
BR9609920A (pt) 1999-07-06
NO980420L (no) 1998-04-03
NO980420D0 (no) 1998-01-30
IL123094A0 (en) 1998-09-24
MX9800945A (es) 1998-04-30
AU713031B2 (en) 1999-11-18
WO1997005870A2 (en) 1997-02-20
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
JPH11511136A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
US6077862A (en) Virus and cancer treatments
EP0821586B1 (en) A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
AU714057B2 (en) A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
SK14298A3 (en) Use of griseofulvin for inhibiting the growth of cancers
SK14198A3 (en) Use of fluconazole for inhibiting the growth of cancers
US5932609A (en) Pharmaceutical composition for inhibiting the growth of cancers
US5929099A (en) Pharmaceutical composition for inhibiting the growth of cancers
MXPA98000998A (en) Use of fluconazole to inhibit the growth of cance
US6110953A (en) Pharmaceutical composition for inhibiting the growth of cancers
MXPA98000945A (en) Use of griseofulvine to inhibit cancer growth
US5908855A (en) Compositions for treating viral infections
MXPA97007809A (en) A pharmaceutical composition containing benzymidazole to inhibit the growth of cance
MXPA98000944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibirel crecimiento de canceres
US20010041678A1 (en) Compositions and methods for treating cancer
MXPA97007808A (en) A pharmaceutical composition containing n-chlorophenyl carbamates and n-chlorofinyl carbamates to inhibit the growth of viruses and cance
AU730920B2 (en) A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers